PMA

P880042: EDAP LT.01 SHOCK WAVE LITHOTRIPTER

FDA PMA · Lithotriptor, extracorporeal shock-wave, urological · Edap International Corp.

Key facts

PMA number P880042
Trade name EDAP LT.01 SHOCK WAVE LITHOTRIPTER
Generic name Lithotriptor, extracorporeal shock-wave, urological
Applicant Edap International Corp.
Owner/operator EDAP Technomed Inc.
Product code LNS
Approval date Dec 12, 1991
Docket number 91M-0507
Notice date Jan 15, 1992
Establishment registration 1287394
FEI number 1287394

At a glance

  • 1–9 Supplements
  • Dec 18, 1996 Latest supplement decision
  • Yes Withdrawn
  • No Summary of safety and effectiveness on file
  • None UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals